Evolution of the Average Target: IRADIMED CORPORATION

Evolution of the Target Price: IRADIMED CORPORATION

Changes in Analyst Recommendations: IRADIMED CORPORATION

51595a88d22c624a8727665c526c0.fFNyzoLAtkVTyWuWisD2mbXg6IkFunf6zwxYLtcLGTQ.UQEf-_Gv7A0Sqi-mz7q_8-LSrv9uyDrXpUcBYuI4KXcuCSaG1LGOdDGZJg~52743e7f0a8e41d9f402cc29193c7297

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
- +21.61%
+48.77%
+36.9%
+67.5%
- - +49.03%
Average +44.76%
Weighted average by Cap. +45.90%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
97.03USD
Average target price
118.00USD
Spread / Average Target
+21.61%
High Price Target
120.00USD
Spread / Highest target
+23.67%
Low Price Target
116.00USD
Spread / Lowest Target
+19.55%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

Roth Capital Partners
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
97.03USD
Average target price
118.00USD
Spread / Average Target
+21.61%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. IRMD Stock
  4. Consensus IRADIMED CORPORATION